DGX
46
3
HRL
33
3
HPE
63
2
ALL
43
3
PNW
53
3
PG
37
2
PPL
57
-2
MCO
59
3
URI
62
-3
WEC
53
5
ESS
42
6
STX
73
-2
HP
32
2
IP
64
2
NEE
54
-11
BMY
37
2
PNC
59
2
UAL
70
4
A
48
2
TSN
42
2
DGX
46
3
HRL
33
3
HPE
63
2
ALL
43
3
PNW
53
3
PG
37
2
PPL
57
-2
MCO
59
3
URI
62
-3
WEC
53
5
ESS
42
6
STX
73
-2
HP
32
2
IP
64
2
NEE
54
-11
BMY
37
2
PNC
59
2
UAL
70
4
A
48
2
TSN
42
2
Financhill
Back

ProShares UltraShort Nasdaq Biotechnology Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23

BIS
ProShares UltraShort Nasdaq Biotechnology

Last Price:
$15.90
Seasonality Move:
-2.58%

7 Day Trial

ALL ACCESS PASS

$ 7

ProShares UltraShort Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares UltraShort Nasdaq Biotechnology has on average historically fallen by 27.4% based on the past 15 years of stock performance.
  • ProShares UltraShort Nasdaq Biotechnology has fallen lower in 13 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 86.67%
  • Is ProShares UltraShort Nasdaq Biotechnology Stock Undervalued?
    The current ProShares UltraShort Nasdaq Biotechnology [BIS] share price is $15.96. The Score for BIS is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will ProShares UltraShort Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares UltraShort Nasdaq Biotechnology has on average historically fallen by 27.4% based on the past 15 years of stock performance.

ProShares UltraShort Nasdaq Biotechnology Stock Rating

Sell
23
ProShares UltraShort Nasdaq Biotechnology (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotechnology overpriced?

  • ProShares UltraShort Nasdaq Biotechnology has fallen lower in 13 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 86.67%

ProShares UltraShort Nasdaq Biotechnology Stock Price History

Is BIS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
25.87
52-Week Low:
14.05

Prediction Charts

Market Cap:
0
Price in USD:
15.96
Volume:
20.3K
Beta:
-1.62

Technical Analysis

SMA50:
18.08
SMA100:
18.26
SMA200:
17.33
52-Wk Change:
11.66%

Stock Predictions

  • Is ProShares UltraShort Nasdaq Biotechnology stock public?
    Yes, ProShares UltraShort Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares UltraShort Nasdaq Biotechnology stock quote today?
    The ProShares UltraShort Nasdaq Biotechnology stock price is 15.96 USD today.
  • How to buy ProShares UltraShort Nasdaq Biotechnology stock online?
    You can buy ProShares UltraShort Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-26 17.53 17.56 17.72 17.47
Jun-27 17.70 17.68 17.79 17.39
Jun-30 17.37 17.71 17.79 17.37
Jul-1 17.53 17.44 17.53 16.88
Jul-2 17.46 16.89 17.46 16.75
Jul-3 16.74 16.74 17.01 16.74
Jul-7 16.71 17.22 17.43 16.71
Jul-8 17.01 16.93 17.01 16.63
Jul-9 16.66 16.03 16.66 16.00
Jul-10 16.14 15.73 16.19 15.71
Jul-11 16.12 16.23 16.27 16.04
Jul-14 16.24 15.85 16.24 15.85
Jul-15 15.90 16.53 16.57 15.90
Jul-16 16.16 15.96 16.26 15.91

ProShares UltraShort Nasdaq Biotechnology Earnings

Data Unavailable

ProShares UltraShort Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares UltraShort Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.